Transplantation of allogeneic peripheral blood stem cells mobilized by recombinant human granulocyte colony stimulating factor

Stem Cells

Volumn 14, Issue 1, 1996, Pages 90-105

  Bensinger, William I ^a   Clift, Reginald A ^b   Anasetti, Claudio ^b   Appelbaum, Frederick A ^b   Demirer, Taner ^b   Rowley, Scott ^b   Sandmaier, Brenda M ^b   Torok Storb, Beverly ^b   Storb, Rainer ^b   Dean Buckner, C ^b  

^a Fred Hutchinson Cancer Research Center   (United States)

^b NONE

Author keywords

Allogeneic; Peripheral blood stem cells; Transplantation

Indexed keywords

CD34 ANTIGEN; COLONY STIMULATING FACTOR 1; FLUOROURACIL; GRANULOCYTE COLONY STIMULATING FACTOR; INTERLEUKIN 2; INTERLEUKIN 6; INTERLEUKIN 8; RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR; STEM CELL FACTOR;

ACCESSORY CELL; ACUTE LYMPHOCYTIC LEUKEMIA; BONE PAIN; CRYOPRESERVATION; GRAFT FAILURE; GRAFT VERSUS HOST REACTION; HLA MATCHING; HUMAN; INFLUENZA; LYMPHOKINE ACTIVATED KILLER CELL; MYALGIA; NONHUMAN; PERIPHERAL BLOOD STEM CELL; PHENOTYPE; REVIEW; STEM CELL TRANSPLANTATION; STROMA CELL; T LYMPHOCYTE; TREATMENT OUTCOME;

EID: 9044220220     PISSN: 10665099     EISSN: None     Source Type: Journal    
DOI: 10.1002/stem.140090     Document Type: Review

References (87)

1. Goodman JW, Hodgson GS. Evidence for stem cells in the peripheral blood of mice. Blood 1962;19:702-714.
2. Cavins JA, Kasakura S, Thomas ED et al. Recovery of lethally irradiated dogs following infusion of autologous marrow stored at low temperature in dimethyl-sulphoxide. Blood 1962;20:730-734.
3. Storb R, Epstein RB, Ragde H et al. Marrow engraftment by allogeneic leukocytes in lethally irradiated dogs. Blood 1967;30:805-811.
4. McCredie KB, Hersh EM, Freireich EJ. Cells capable of colony formation in the peripheral blood of man. Science 1971;171:293-294.
5. Kessinger A, Smith DM, Strandjord SE et al. Allogeneic transplantation of blood-derived, T cell-depleted hemopoietic stem cells after myeloablative treatment in a patient with acute lymphoblastic leukemia. Bone Marrow Transplant 1989;4:643-646.
6. Bensinger W, Singer J, Appelbaum F et al. Autologous transplantation with peripheral blood mononuclear cells collected after administration of recombinant granulocyte stimulating factor. Blood 1993;81:3158-3163
7. Bensinger WI, Longin K, Appelbaum F et al. Peripheral blood stem cells (PBSCs) collected after recombinant granulocyte colony stimulating factor (rhG-CSF): an analysis of factors correlating with the tempo of engraftment after transplantation. Br J Haematol 1994;87:825-831.
8. Weaver CH, Buckner CD, Longin K et al. Syngeneic transplantation with peripheral blood monotiuclear cells collected after the administration of recombinant human granulocyte colony-stimulating factor. Blood 1993;82:1981-1984.
9. Dreger P, Hafurlach T, Eckstein V et al. G-CSF-mobilized peripheral blood progenitor cells for allogeneic transplantation: safety, kinetics of mobilization, and composition of the graft. Br J Haematol 1994;87:609-613.
10. Schwinger W. Single dose of filgrastim (rhG-CSF) increases the number of hematopoietic progenitors in the peripheral blood of adult volunteers. Bone Marrow Transplant 1993;11:489-492.
11. Bensinger WI, Price TH, Dale DC et al. The effects of daily recombinant human granulocyte colony stimulating factor administration on normal granulocyte donors undergoing leukapheresis. Blood 1993;81:1883-1888.
12. Casper CB, Seger RA, Berger J. Effective stimulation of donors in granulocyte transfusions with recombinant methionyl granulocyte colony-stimulating factor. Blood 1993;81:2866-2871.
13. Dreger P, Suttorp M, Haferlach T et al. Allogeneic granulocyte colony-stimulating factor-mobilized peripheral blood progenitor cells for treatment of engraftment failure after bone marrow transplantation. Blood 1993;81:1404-1409.
14. Russell NH, Hunter A, Rogers S et al. Peripheral blood stem cells as an alternative to marrow for allogeneic transplantation. Lancet 1993;341:1482.
15. Goldman J. Peripheral blood stem cells for allografting. Blood 1995;85:1413-1415.
16. Russell NH, Hunter AE. Peripheral blood stem cells for allogeneic transplantation. Bone Marrow Transplant 1994;13:353-355.
17. Rice A, Reiffers J. Mobilized blood stem cells: immunophenotyping and functional characteristics. J Hematother 1992;1:19-26.
18. + cells and their subpopulations from normal peripheral blood and bone marrow using multicolor flow cytometry. Blood 1991;77:2591-2596.
19. + cells. Blood 1994:84:2930-2939.
20. Rice A, Barbot C, Lacombe F et al. 5-fluorouracil permits access to a primitive subpopulation of peripheral blood stem cells. STEM CELLS 1993;11:326-335.
21. Rice A, Boiron JM, Barbot C et al. Cytokine-mediated expansion of 5-FU-resistant peripheral blood stem cells. Exp Hematol 1995;23:303-308.
22. McQuaker G, Haynes AP, Long SG et al. Study of the release of CD34 cells and colony forming cells in healthy subjects using G-CSF. Bone Marrow Transplant 1995:15(suppl 2):S27a.
23. Scott MA, Jestice HK, Apperley JF. Quality and quantity of progenitor cells in mobilized peripheral blood. Bone Marrow Transplant 1994;2:172.
24. Weaver CH, Longin K, Buckner CD et al. Lymphocyte content in peripheral blood mononuclear cells collected after the administration of recombinant human granulocyte colony-stimulating factor. Bone Marrow Transplant 1994;13:411-415.
25. Bensinger WI, Weaver CH, Appelbaum FR et al. Transplantation of allogeneic peripheral blood stem cells mobilized by recombinant human granulocyte colony-stimulating factor. Blood 1995;85:1655-1658.
26. Matsunaga T, Sakamaki S, Kohogo Y et al. Recombinant human granulocyte colony-stimulating factor can mobilize sufficient amounts of peripheral blood stem cells in healthy volunteers for allogeneic transplantation. Bone Marrow Transplant 1993;11:103-108.
27. Körbling M, Przepiorka D, Huh YO et al. Allogeneic blood stem cell transplantation for refractory leukemia and lymphoma: potential advantage of blood over marrow allografts. Blood 1995;85:1659-1665.
28. Neubauer MA, Benyunes MC, Thompson JA et al. Lymphokine-activated killer (LAK) precursor cell activity is present in infused peripheral blood stem cells and in the blood after autologous peripheral blood stem cell transplantation. Bone Marrow Transplant 1994;13:311-316.
29. Verbik DJ, Jackson JD, Pirruccello SJ et al. Functional and phenotypic characterization of human peripheral blood stem cell harvests: a comparative analysis of cells from consective collections. Blood 1995;7:1964-1970.
30. Carbonell F, Calvo W, Fliedner TM et al. Cytogenetic studies in dogs after total body irradiation and allogeneic transfusion with cryopreserved blood mononuclear cells: observations in long-term chimeras. Int J Cell Cloning 1984;2:81-88.
31. Molineux G, Pojda Z, Hampson IN et al. Transplantation potential of peripheral blood stem cells induced by granulocyte colony-stimulating factor. Blood 1990;76:2153-2158.
32. Bungart B, Loeffler M, Goris H et al. Differential effects of recombinant human colony stimulating factor (rh-CSF) on stem cells in marrow, spleen and peripheral blood in mice. Br J Haematol 1990;76:174-179.
33. Molineux G, Migdalska A, Szmitkowski M et al. The effects of hematopoiesis of recombinant stem cell factor (ligand for c-kit) administered in vivo to mice either alone or in combination with granulocyte colony-stimulating factor. Blood 1991;78:961-966.
34. Neben S, Marcus K, Mauch P. Mobilization of hematopoietic stem and progenitor cell subpopulations from the marrow to the blood of mice following cyclophosphamide and/or granulocyte colony-stimulating factor. Blood 1993;81:1960-1967.
35. Bodine DM, Seidel NE, Zsebo KM et al. In vivo administration of stem cell factor to mice increases the absolute number of pluripotent hematopoietic stem cells. Blood 1993;82:445-455.
36. Bodine DM, Seidel NE, Gale MS et al. Efficient retrovirus transduction of mouse pluripotent hematopoietic stem cells mobilized into the peripheral blood by treatment with granulocyte colony-stimulating factor and stem cell factor. Blood 1994;84:1482-1491.
37. Briddell RA, Hartley CA, Smith KA et al. Recombinant rat stem cell factor synergizes with recombinant human granulocyte colony-stimulating factor in vivo in mice to mobilize peripheral blood progenitor cells that have enhanced repopulating potential. Blood 1993;82:1720-1723.
38. Laterveer L, Lindley IJD, Hamilton MS et al. Interleukin 8 induces rapid mobilization of hematopoietic stem cells with radioprotective capacity and long-term myelolymphoid repopulating ability. Blood 1995;85:2269-2275.
39. + colony-forming cell types in blood and marrow of baboons. Blood 1992;80:920-927.
40. Laterveer L, Lindley IJD, Heemskerk D et al. Rapid mobilization of stem cells in rhesus monkeys after a single i.v. injection of IL-8. Bone Marrow Transplant 1995:(suppl 2):S7.
41. De Revel T, Appelbaum FR, Storb R et al. Effects of granulocyte colony stimulating factor and stem cell factor, alone and in combination, on the mobilization of peripheral blood cells that engraft lethally irradiated dogs. Blood 1994;83:3795-3799.
42. Kiem H-P, Darovsky B, von Kalle C et al. Retrovirus-mediated gene transduction into canine peripheral blood repopulating cells. Blood 1994;83:1467-1473.
43. Sandmaier BM, Kiem HP, de Revel T et al. Peripheral blood stem cell transplantation in the canine model Bone Marrow Transplant 1994;(suppl 2):139a.
44. Sandmaier BM, Bastianelli C, Santos E et al. Evaluation of peripheral blood mononuclear cell dose and T-cell subpopulation required for enhancement of engraftment in unrelated dog leukocyte antigen (DLA)-nonidentical marrow transplants. Bone Marrow Transplant 1994;84(suppl 1):347a.
45. Gerritsen WR, O'Reilly RJ. Granulocyte colony-stimulating factor (CSF) but not interleukin 1 (IL-1). IL-3. and granulocyte-macrophage CSF protect bone marrow progenitor cells from suppression by allosensitized cytotoxic T cells. Blood 1994;84:1906-1912.
46. Gratwohl A, Baldomero H, John L et al. Allogeneic G-CSF mobilised peripheral blood stem cell transplants (PBSC) in rabbits. Bone Marrow Transplant 1994;(suppl 2):139a.
47. Nemunaitis J, Rosenfeld C, Collins R et al. Pilot trial of allogeneic transplant combining peripheral blood and bone marrow in patients with refractory hematologic malignancy. ASCO 1994:417a.
48. Suzue T, Kawano Y, Takaue Y et al. Cell processing protocol for allogeneic peripheral blood stem cells mobilized by granulocyte colony-stimulating factor. Exp Hematol 1994;22:888-892.
49. DiPersio J, Martin B, Abboud C et al. Allogeneic BMT using bone marrow and CD34-selected mobilized PBSC: comparison to BM alone and mobilized PBSC alone. Blood 1994:84(10):91a.
50. Aversa F, Tabilio A, Terenzi A et al. Successful engraftment of T-cell-depleted halpoidentical "Three-Loci" incompatible transplants in leukemia patients by addition of recombinant human granulocyte colony-stimulating factor-mobilized peripheral blood progenitor cells to bone marrow inoculum. Blood 1994;11:3948-3955.
51. Sasaki A, Tsukaguchi M, Hirai M et al. Transplantation of allogeneic peripheral blood stem cells after myeloablative treatment of a patient in blastic crisis of chronic myelocytic leukemia. Am J Hematol 1994;47:45-49.
52. Fritsch G, Fischmeister G, Haas OA et al. Peripheral blood hematopoietic progenitor cells of cytokine-stimulated healthy donors as an alternative for allogeneic transplantation (Letter). Blood 1994;83:3420-3421.
53. Tanaka J, Imamura M, Zhu X et al. Potential benefit of recombinant human granulocyte colony-stimulating factor-mobilized peripheral blood stem cells for allogeneic transplantation (Letter). Blood 1994;84:3595-3596.
54. Oblon DJ, Paul S, Oblon MB et al. Allogeneic peripheral blood stem cell transplants: preliminary results. Bone Marrow Transplant 1994;84(10):94a.
55. Maiolino I, Buscemi F, Seime R et al. G-CSF mobilized PBSC for allogeneic transplantation. Bone Marrow Transplant 1994;84(10):92a.
56. Laporte JP, Lesage S, Douay L et al. Allogeneic transplantation with peripheral blood hematopoietic progenitors mobilized with G-CSF. Bone Marrow Transplant 1994;84(10):90a.
57. Russell JA, Bowen T, Brown C et al. Allogeneic blood cell transplants for haematological malignancy: comparison of engraftment and graft-versus-host disease with bone marrow transplantation. Lancet (in press).
58. Bacigalupo A, Majolino I, Van Lint MT et al. Transplantation of rh-G-CSF mobilized allogeneic peripheral blood cells from HLA identical sibling donors. Bone Marrow Transplant 1995;15(suppl 2):S5a.
59. Link H, Arseniev L, Bahre O et al. Transplantation of allogeneic peripheral blood progenitor cells alone or in addition to bone marrow. Bone Marrow Transplant 1995;15(suppl 2):S5a.
60. Lane TA, Law P, Maruyama M et al. Harvesting and enrichment of hematopoietic progenitor cells mobilized into the peripheral blood of normal donors by granulocyte-macrophage colony-stimulating factor (GM-CSF) or G-CSF; potential role in allogeneic marrow transplantation. Blood 1995;85:275-282.
61. Wiesneth M, Schreiner T, Friedrich W et al. Mobilization of allogeneic blood stem cells and T-cell depletion of the graft. Bone Marrow Transplant 1995;(suppl 2):S28a.
62. Friedrich W, Schreiner M, Muller S et al. Simultaneous grafting of T cell depleted marrow and blood stem cells from HLA nonidentical family donors. Bone Marrow Transplant 1995;(suppl 2):S28a.
63. Rozman C, Urbano-Ispizua A, Sierra J et al. Allogeneic peripheral blood stem cell (PBSC) transplantation. Report of four cases. Bone Marrow Transplant 1995;15(suppl 2):S27a.
64. Majolino I, Buscemi F, Scime R et al. PBSC Mobilization with G-CSF 16 μg/kg and their apheretic collection in normal donors for use in allogeneic transplantation. Bone Marrow Transplant 1995;15(suppl 2):S27a.
65. Gurman G, Kahveci G, Akan H et al. Allogeneic peripheral blood stem cell transplantation as a second transplant for severe aplastic anemia (Letter). Bone Marrow Transplant 1995;15:485-488.
66. Schmitz N, Dreger P, Suttorp M et al. Primary transplantation of allogeneic peripheral blood progenitor cells mobilised by Filgrastim (G-CSF). Blood 1995;85:1666-1672.
67. Russell JA, Luider J, Weaver M et al. Collection of progenitor cells for allogeneic transplantation from peripheral blood of normal donors. Bone Marrow Transplant 1995,15:111-115.
68. Molina L, Chabannon C, Viret F et al. Granulocyte colony-stimulating factor-mobilized allogeneic peripheral blood stem cells for rescue of graft failure after allogeneic bone marrow transplantation in two patients with acute myeloblastic leukemia in first complete remission. Blood 1995;85:1678-1679.
69. + selection systems or CAMPATH-1. Exp Hematol 1995;23:147-154.
70. Sica S, Rutella S, Di Mario et al. G-CSF in healthy subjects for HLA-identical donor leukocytes collection. Bone Marrow Transplant 1995;15(suppl 2):S27a.
71. Arseniev L, Kadar JG, Berenson RJ et al. Allogeneic peripheral blood progenitor cell mobilization, collection and immunoselection. Bone Marrow Transplant 1995;15(suppl 2):S5a.
72. Russell J, Bowen T, Brown C et al. Single centre experience of allogeneic blood cell transplants: accelerated engraftment without increased acute GVHD compared with BMT. Bone Marrow Transplant 1995;15(suppl 2):S5a.
73. Martínez JA, Picón I, Carral A et al. Allogeneic peripheral blood progenitor cells mobilized by G-CSF (filgrastim) for a second transplant in a patient with acute myeloid leukemia in relapse. Bone Marrow Transplant 1995;15:149-151.
74. + blood cells alone for allogeneic (allo) transplant. Proc Am Soc Clin Oncol 1995;14:76a.
75. Pagliuca A, Mijovic A, Jeanes A et al. Delayed platelet regeneration following allogeneic peripheral blood progenitor cell transplantation for acute leukemia. Bone Marrow Transplant 1995;15(suppl 2):S29a.
76. Nash RA, Burstein SA, Storb R et al. Thrombocytopenia in dogs induced by granulocyte-macrophage colony-stimulating factor: increased destruction of circulating platelets. Blood 1995;86:1765-1775.
77. Stone RM, Neuberg D, Soiffer R et al. Myelodysplastic syndrome as a late complication following autologous bone marrow transplantation for non-Hodskin's lymphoma. J Clin Oncol 1994;12:2535-2342.
78. Buckner CD, Petersen FB, Bolonesi BA. Bone marrow donors. In: Forman SJ, Blume KG, Thomas ED, eds. Bone Marrow Transplant. Boston, MA: Blackwell Scientific Publications, 1994.259-270.
79. Anasetti C, Amos D, Beatty PG et al. Effect of HLA compatibility on engraftment of bone marrow transplants in patients with leukemia or lymphoma. N Engl J Med 1989;320:197-204.
80. Storb R, Etzioni R, Anasetti C et al. Cyclophosphamide combined with antithymocyte globulin in preparation for allogeneic marrow transplants in patients with aplastic anemia. Blood 1994;84:941-949.
81. Kernan NA. T-cell depletion for prevention of graft-versus-host disease. In: Forman SJ, Blume KG, Thomas ED, eds. Bone Marrow Transplant. Boston, MA: Blackwell Scientific Publications. 1994:124-135.
82. Niederwteser D, Pepe M, Storb R et al. for the Seattle Marrow Transplant Team. Improvement in rejection, engraftment rate and survival without increase in graft-versus-host disease by high marrow cell dose in patients transplanted for aplastic anemia. Br J Haematol 1988;69:23-28.
83. O'Reilly RJ, Kernan N, Cunningham I et al. Soybean lectin agglutination and E-rosette depletion for removal of T-cells from HLA-identical and non-identical marrow grafts administered for the treatment of leukemia. In: Martelli MF, Grignani F, Reisner Y, eds. T-Cell Depletion in Allogeneic Bone-Marrow Transplantation. Rome: Ares-Serono Symposia, 1988:123-129.
84. Bolger GB, Sullivan KM, Storb R et al. Second marrow infusion for poor graft function after allogeneic marrow transplantation. Bone Marrow Transplant 1986;1:21-30.
85. Kook H, Kim HJ, Hwang TJ et al. The use of allogeneic peripheral blood stem cell (PBSC) boost in the treatment of late graft failure after allogeneic bone marrow transplant (BMT) in a patient with severe aplastic anemia. Proc Am Soc Clin Oncol 1995,14:77a.
86. Anasetti C, Martin PJ, Storb R et al. Engraftment of allogeneic hematopoietic stem cells in patients conditioned only with anti-CD3 monoclonal antibody BC3 plus methylprednisolone. Blood 1994;84(suppl 1):249a.
87. Kolb HJ, Mittermüller J, Clemm Ch et al. Donor leukocyte transfusions for treatment of recurrent chronic myelogenous leukemia in marrow transplant patients. Blood 1990;76:2462-2465.